Aimei Health Technology Co., Ltd. financial data

Symbol
AFJK, AFJKR, AFJKU on Nasdaq
Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 18 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.4% % -100%
Debt-to-equity -101% % 43%
Return On Equity -55% %
Return On Assets 2.7% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6,121,733 shares
Common Stock, Shares, Outstanding 2,126,000 shares 0%
Common Stock, Value, Issued $213 USD 0%

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) $987,191 USD 35%
Nonoperating Income (Expense) $2,392,955 USD -49%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $1,405,764 USD -53%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current $24,948 USD -80%
Assets $45,468,518 USD -38%
Accrued Liabilities, Current $292,609 USD 106%
Liabilities, Current $2,774,428 USD 1102%
Liabilities $3,464,428 USD 276%
Retained Earnings (Accumulated Deficit) $3,439,693 USD -332%
Stockholders' Equity Attributable to Parent $3,439,480 USD -332%
Liabilities and Equity $45,468,518 USD -38%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $224,009 USD -34%
Net Cash Provided by (Used in) Financing Activities $30,584,654 USD
Net Cash Provided by (Used in) Investing Activities $30,787,800 USD
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 2,126,000 shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $20,863 USD 88%
Unrecognized Tax Benefits $0 USD